Tyrosine and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tyrosine and Claritin. Common interactions include headache among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people who take Tyrosine and Claritin have. It is created by eHealthMe based on reports of 12 people who take Tyrosine and Claritin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

12 people who take Tyrosine and Claritin together, and have interactions are studied.


What is Tyrosine?

Tyrosine has active ingredients of tyrosine. It is often used in depression. eHealthMe is studying from 604 Tyrosine users for its effectiveness, alternative drugs and more.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 67,339 Claritin users for its effectiveness, alternative drugs and more.

Number of Tyrosine and Claritin reports submitted per year:

Tyrosine and Claritin drug interactions.

Common Tyrosine and Claritin drug interactions by gender *:

female:

  1. Headache
  2. Abdominal pain upper
  3. Cough
  4. Fatigue
  5. Gastritis
  6. Heart rate decreased
  7. Herpes zoster
  8. Hypersensitivity
  9. Lymphadenopathy
  10. Migraine

male:

  1. Arthralgia
  2. Fatigue
  3. Muscle spasms
  4. Nasopharyngitis
  5. Neck pain
  6. Eye haemorrhage
  7. Injection site bruising
  8. Amino acid level decreased
  9. Confusional state
  10. Cough

Common Tyrosine and Claritin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Headache
  3. Injection site bruising
  4. Injection site erythema

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain upper
  2. Cough
  3. Nasopharyngitis
  4. Weight increased
  5. Autoimmune thyroiditis
  6. Blood pressure decreased
  7. Body height decreased
  8. Hangover
  9. Hypotension
  10. Malaise

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 33.33%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 16.67%
  3. Migraine (headache): 2 people, 16.67%
  4. Urination - Painful: 1 person, 8.33%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 8.33%
  6. Peripheral Swelling: 1 person, 8.33%
  7. Ill-Defined Disorder: 1 person, 8.33%
  8. Hypersensitivity: 1 person, 8.33%
  9. High Blood Pressure: 1 person, 8.33%
  10. High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tyrosine and Claritin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Tyrosine and Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Claritin interactions:

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tyrosine and loratadine (the active ingredients of Tyrosine and Claritin, respectively), and Tyrosine and Claritin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tyrosine and Claritin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: